Vatnak Vat-Ho
Chief Business Officer · Akari Therapeutics Plc
Individual
- 2026
- Oct 14, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vatnak Vat-Ho files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M in AKTX purchases and sales in the last 12 months
- Abizer Gaslightwala - $437K in AKTX purchases and sales in the last 12 months
- Raymond Prudo-Chlebosz - $406K in AKTX purchases and sales in the last 12 months
- Samir Rashmikant Patel - $344K in AKTX purchases and sales in the last 12 months
- Sandip I. Patel - $162K in AKTX purchases and sales in the last 12 months
- Robert B. Bazemore - $62K in AKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vatnak Vat-Ho?
Vatnak Vat-Ho is a corporate insider, tracked as Chief Business Officer of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vatnak Vat-Ho submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.